Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W McKee

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
The Lancet. Infectious Diseases|August 12, 2024
Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trialPaul Kim, Ana M Sanchez, Taylor J R Penke, et al.
Lancet (London, England)|April 26, 1980
Epidemiology and clinical practiceE D Acheson, D J Barker, N J Blacklock, et al.
Physical Review Letters|November 13, 2023
Second Data Release from the European Pulsar Timing Array: Challenging the Ultralight Dark Matter ParadigmClemente Smarra, Boris Goncharov, Enrico Barausse, et al.
Physical Review Letters|October 13, 2007
Transverse beam spin asymmetries in forward-angle elastic electron-proton scatteringD S Armstrong, J Arvieux, R Asaturyan, et al.
Physical Review Letters|October 4, 2005
Strange-quark contributions to parity-violating asymmetries in the forward g0 electron-proton scattering experimentD S Armstrong, J Arvieux, R Asaturyan, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
The Lancet. Infectious Diseases|August 12, 2024
Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trialPaul Kim, Ana M Sanchez, Taylor J R Penke, et al.
Lancet (London, England)|April 26, 1980
Epidemiology and clinical practiceE D Acheson, D J Barker, N J Blacklock, et al.
Physical Review Letters|November 13, 2023
Second Data Release from the European Pulsar Timing Array: Challenging the Ultralight Dark Matter ParadigmClemente Smarra, Boris Goncharov, Enrico Barausse, et al.
Physical Review Letters|October 13, 2007
Transverse beam spin asymmetries in forward-angle elastic electron-proton scatteringD S Armstrong, J Arvieux, R Asaturyan, et al.
Physical Review Letters|October 4, 2005
Strange-quark contributions to parity-violating asymmetries in the forward g0 electron-proton scattering experimentD S Armstrong, J Arvieux, R Asaturyan, et al.
Pageof 8